CHED 780 |
| Carbonyl reductase (CR) is an enzyme that catalyzes the NADPH-dependent reduction of various carbonyls. CR has been implicated in the cardiotoxicity often observed in cancer patients after treatment with anthracycline drugs. Given the role of CR in the cardiotoxicity, it is important to fully understand the enzyme's structure and function. The present study examines how CR binds small molecules, including known inhibitors of CR. Using fluorimetry, the binding of several enzyme-small molecule complexes were studied. NADPH and NADP+ were found to bind to the free enzyme with µM affinities. NADP+ and the fluorescent probe 8-anilino-1-naphthalenesulfonic acid (ANS) were found to bind CR simultaneously without competing. This information, coupled with the knowledge that ANS does not inhibit CR, suggests the presence of a ligand binding site other than the active site of the enzyme, which may have implications for CR inhibition. NIH/P20RR016454, NIH/R15CA102119-01 |
|
Undergraduate Research Poster Session: Biochemistry
2:00 PM-4:00 PM, Monday, April 7, 2008 Morial Convention Center -- Hall A, Poster
Division of Chemical Education |